Cancer and Clot: Between a Rock and a Hard Place

Journal of the American College of Cardiology

Volumn 70, Issue 8, 2017, Pages 939-941

  Yeh, Edward T H ^a   Chang, Hui Ming ^a  

^a University of Missouri   (United States)

Author keywords

myocardial infarction; onco cardiology; stroke; thromboembolism; Trousseau syndrome

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CYSTEINE PROTEINASE; L SELECTIN; MUCIN; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; THROMBOPLASTIN; VASCULOTROPIN RECEPTOR;

ARTERIAL THROMBOEMBOLISM; BINDING SITE; BRAIN ISCHEMIA; CARDIOLOGIST; CARDIOVASCULAR RISK; COMORBIDITY; DISEASE ASSOCIATION; EDITORIAL; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; LUNG CANCER; MALIGNANT NEOPLASM; ONCOGENE K RAS; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PTEN GENE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; TUMOR SUPPRESSOR GENE; VEGFR GENE; NEOPLASM; THROMBOSIS;

HUMANS; NEOPLASMS; THROMBOEMBOLISM; THROMBOSIS;

EID: 85026806552     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.07.719     Document Type: Editorial

References (16)

1. Trousseau, A., A Piegmasia Alba Dolens. Lectures Clin Med 5 (1865), 281–332.
2. Varki, A., Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 110 (2007), 1723–1729.
3. Navi, B.B., Reiner, A.S., Kamel, H., et al. Risk of arterial thromboembolisms in patients with cancer. J Am Coll Cardiol 70 (2017), 926–938.
4. Moslehi, J.J., Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med 375 (2016), 1457–1467.
5. Muhsin-Sharafaldine, M.R., Saunderson, S.C., Dunn, A.C., Faed, J.M., Kleffmann, T., McLellan, A.D., Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. Oncotarget 7 (2016), 56279–56294.
6. Rak, J., Milsom, C., May, L., Klement, P., Yu, J., Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost 32 (2006), 54–70.
7. Rak, J., Yu, J.L., Luyendyk, J., Mackman, N., Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res 66 (2006), 10643–10646.
8. Gordon, S.G., Hasiba, U., Cross, B.A., Poole, M.A., Falanga, A., Cysteine proteinase procoagulant from amnion-chorion. Blood 66 (1985), 1261–1265.
9. Falanga, A., Gordon, S.G., Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. Biochemistry 24 (1985), 5558–5567.
10. Wahrenbrock, M., Borsig, L., Le, D., Varki, N., Varki, A., Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112 (2003), 853–862.
11. van't Spijker, A., Trijsburg, R.W., Duivenvoorden, H.J., Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59 (1997), 280–293.
12. Kangas, M., Henry, J.L., Bryant, R.A., Posttraumatic stress disorder following cancer. A conceptual and empirical review. Clin Psychol Rev 22 (2002), 499–524.
13. Leor, J., Kloner, R.A., The Northridge earthquake as a trigger for acute myocardial infarction. Am J Cardiol 77 (1996), 1230–1232.
14. Yeh, E.T., Chang, H.M., Oncocardiology—past, present, and future: a review. JAMA Cardiol 1 (2016), 1066–1072.
15. Sarkiss, M.G., Yusuf, S.W., Warneke, C.L., et al. Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer 109 (2007), 621–627.
16. Iliescu, C., Durand, J.B., Kroll, M., Cardiovascular interventions in thrombocytopenic cancer patients. Tex Heart Inst J 38 (2011), 259–260.